Table 1.
Key Encoded Proteins that Are Highly Involved in Mediating Pathway Activity in MRUCD200/CD200R1 and MRUnot CD200/CD200R1 Populations
Key Proteins | Pathways |
---|---|
Key proteins highly expressed in MRUCD200/CD200R1 populationa | highly active pathways in MRUCD200/CD200R1 populationa |
Complement (C1q, C3, C3a, C3b, C4b, C6) | complement pathway |
Key proteins highly expressed in MRUnot CD200/CD200R1 populationb | highly active pathways in MRUCD200/CD200R1 populationa |
vWF | coagulation system |
IL6 | TREM1 signaling |
MAGI | pTEN signaling |
Key proteins highly expressed in MRUnot CD200/CD200R1 populationb | highly active pathways in MRUnot CD200/CD200R1 populationb |
PI3 kinase | eNOS signaling; nitric oxide signaling; IL-8 signaling; Tec signaling; Gαq signaling; inhibition of angiogenesis by TSP1; endothelin-1 singling; anti-proliferative role of somatostatin receptor 2; thrombin signaling; HMGB1 signaling; p70s6k signaling; integrin signaling; hepatocyte growth factor (HGF) signaling |
ERK 1/2 | nitric oxide signaling; IL-8 signaling; antiproliferative role of somatostatin receptor 2; vascular endothelial growth factor (VEGF) family of ligand receptor interactions; HMGB1 signaling; prolactin signaling; agrin interactions; Stat3 signaling; nuclear factor (NF)-κB signaling; thrombin signaling; acute-phase response signaling; CAMP-mediated signaling; chemokine signaling; Rho signaling; role of NFAT in cardiac hypertrophy; renin-angiotensin signaling; HGF signaling; mouse embryonic stem cell pluripotency |
p38 MAPK | inhibition of angiogenesis by TSP1; thrombin signaling; acute-phase response; type 1 diabetes; HMGB1 signaling; iNOS signaling; chemokine signaling; IL-1 signaling; VEGF signaling; TGFβ signaling; mouse embryonic stem cell pluripotency |
PKC | nitric oxide signaling; IL-8 signaling; eNOS signaling; Inhibition of angiogenesis by TSP1; p70s6k signaling |
Gα | Tec kinase signaling; endothelin 1 signaling; signaling by Rho family GTPases; IL-1 signaling |
Gβ | Tec kinase signaling; IL-8 signaling; Gαq signaling; cardiac β-adrenergic signaling; antiproliferative role of somatostatin receptor 2; thrombin signaling; role of NA in cardiac hypertrophy; signaling by Rho family GTPases; α-adrenergic signaling; IL-1 signaling |
GƳ | Tec kinase signaling; IL-8 signaling; Gαq signaling; cardiac β-adrenergic signaling; antiproliferative role of somatostatin receptor 2; thrombin signaling; role of NA in cardiac hypertrophy; signaling by Rho family GTPases; α-adrenergic signaling; IL-1 signaling |
RAS | phospholipase signaling; thrombin signaling; acute-phase response; NF-κB signaling; integrin signaling; antiproliferative role of somatostatin receptor 2; thrombin signaling; glioma invasiveness phospholipase signaling; thrombin signaling; acute-phase response; NF-κB signaling; integrin signaling; HMGB1 signaling; agrin interactions; P70S6K signaling; α-adrenergic signaling; NRF-mediated stress response; prolactin signaling; p21 activated kinase (PAK) signaling |
IκB | Gαq signaling; acute-phase response signaling; type 1 diabetes; iNOS signaling |
JNK | IL-8 signaling; Tec signaling; inhibition of angiogenesis by TSP1; HMGB1 signaling; type 1 diabetes; Rho signaling; IL-1 signaling; PAK signaling; HGF signaling |
FAK | glioma invasiveness; IL-8 signaling; Tec signaling; agrin interactions; Rho signaling; chemokine signaling; integrin signaling |
RHO | glioma invasiveness; HMGB1 signaling; IL-8 signaling; Gαq signaling |
VEGF and receptors 1/2/3/C | nitric oxide signaling; IL-8 signaling; VEGF signaling |
CAVEOLIN-1 | nitric oxide signaling; eNOS signaling; integrin signaling |
eNOS | eNOS signaling; nitric oxide signaling; VEGF signaling |
P21CIP1 | HGF pathway |
Key proteins highly expressed in MRU CD200/CD200R1 populationa | highly active pathways in MRUnot CD200/CD200R1 populationb |
SRC | IL-8 pathway; antiproliferative role of somatostatin receptor 2; thrombin pathway; agrin interactions; Stat3 pathway; integrin pathway; cAMP-mediated signaling; endothelin 1 signaling; phospholipase C signaling; role of NA in cardiac hypertrophy; p70s6k signaling; integrin signaling; VEGF signaling; Gα12-13 signaling |
BTK | Gαq signaling; phospholipase C signaling; NF-κB/PI3K signaling; p70s6k signaling; Gα12-13 signaling |
PKC | VEGF signaling |
SHIP | NF-κB/PI3K signaling |
See also Figures S1 and S2.
Divergent pathway activity in the MRU subpopulations was determined by IPA.
Corresponds to MRU separation presented in Figure 1: MRUCD200/CD200R1 expresses high levels of both CD200 and CD200R1.
Corresponds to MRU separation presented in Figure 1: MRUnot CD200/CD200R1 represents the rest of the MRUs.